Phase I Study of Gemcitabine (Gemzar) and UFT [tegafur/uracil],/Leucovorin [folinic acid].
Phase of Trial: Phase I
Latest Information Update: 05 Apr 2013
At a glance
- Drugs Folinic acid (Primary) ; Gemcitabine (Primary) ; Tegafur/uracil (Primary)
- Indications Cancer
- Focus Adverse reactions
- 18 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Apr 2010 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
- 29 Sep 2005 New trial record.